Last reviewed: 11 March 2026
Key points
- Acute Aspergillus pneumonia is a rare lung infection caused by inhaling very large numbers of Aspergillus fungal spores.
- It can occur in people with normal immune systems, usually after a single heavy environmental exposure.
- Typical exposures include mouldy hay, compost, bark chippings, agricultural dust, or similar environments with high fungal spore levels.
- Symptoms resemble severe pneumonia and include fever, breathlessness and cough.
- Diagnosis requires specialist tests because the illness can resemble other lung diseases such as bacterial pneumonia or hypersensitivity pneumonitis.
- Treatment usually requires hospital care and antifungal medication.
Table of contents
Overview
Acute Aspergillus pneumonia is a rare form of lung infection caused by fungi from the genus Aspergillus. It is sometimes described as Aspergillus pneumonitis after heavy exposure.
Unlike most forms of aspergillosis, which occur in people with weakened immune systems or pre-existing lung disease, this condition can occasionally occur in otherwise healthy individuals.
Most reported cases follow a short but intense exposure to very large numbers of fungal spores. These exposures may occur in environments where organic material is decomposing.
Examples include:
- handling mouldy hay or grain
- working with compost or tree-bark chippings
- agricultural or forestry work
- heavy exposure to organic dust
- rare events such as near-drowning in contaminated water
In these situations, a large number of fungal spores may be inhaled over a short period. In rare cases this appears to overwhelm the lung’s natural defence systems and cause infection or severe inflammation.
Researchers are also examining whether heavy exposure to mould in damp indoor environments may occasionally contribute to illness, although the relationship between household mould exposure and fungal lung infection remains complex and is still being studied.
Symptoms
Symptoms usually develop within days of exposure and may resemble severe pneumonia.
- fever (often above 38°C)
- shortness of breath
- wheezing
- rapid or shallow breathing
- persistent cough
- cough producing mucus
- chest pain that worsens when breathing deeply
- fatigue or weakness
In severe cases symptoms may worsen rapidly and require hospital treatment.
Causes
Acute Aspergillus pneumonia is usually associated with sudden inhalation of very large numbers of fungal spores.
Aspergillus fungi are common in the natural environment and are found in:
- soil
- compost
- decaying plant material
- organic dust
- damp or mouldy environments
Most people breathe in small numbers of these spores every day without becoming ill. Normally the lungs clear them efficiently using mucus and immune defence mechanisms.
In rare circumstances, however, extremely heavy exposure may overwhelm these defences and lead to infection or severe inflammation in the lungs.
Researchers are still studying why this occurs in only a small number of individuals. Possible contributing factors include:
- extremely high spore exposure
- temporary irritation or damage to the airway lining
- individual variation in immune response
Diagnosis
Diagnosing acute Aspergillus pneumonia can be difficult because its symptoms are similar to several other lung conditions.
It may be confused with:
- bacterial pneumonia
- viral pneumonia
- hypersensitivity pneumonitis (extrinsic allergic alveolitis)
- other inflammatory lung diseases
A careful medical history is important, particularly recent exposure to environments with high fungal spore levels.
Tests used in diagnosis may include:
- chest X-ray
- CT scan of the lungs
- sputum or respiratory samples for fungal testing
- blood tests
- bronchoscopy to obtain lung samples
These investigations help doctors confirm the presence of Aspergillus and rule out other causes of pneumonia.
Treatment
Patients with suspected acute Aspergillus pneumonia usually require hospital assessment and monitoring.
Treatment commonly includes:
- intravenous antifungal medication
- oxygen therapy if breathing is affected
- supportive care for pneumonia
Antifungal medications used may include:
- voriconazole
- isavuconazole
- amphotericin B in some situations
Early diagnosis and treatment are important because severe fungal pneumonia can worsen quickly if untreated.
Prognosis
The outlook depends on the severity of the illness and how quickly treatment begins.
Many patients recover with appropriate antifungal therapy and supportive care. However, untreated fungal pneumonia can be life-threatening.
Common questions
Is this condition common?
No. Acute Aspergillus pneumonia is rare, particularly in people with normal immune systems.
Can normal household mould cause pneumonia?
Everyday exposure to mould spores is extremely common and rarely causes infection. Most reported cases involve unusually heavy exposure to large numbers of spores.
Is this the same as invasive aspergillosis?
No. Invasive aspergillosis usually occurs in people with severely weakened immune systems, such as those receiving chemotherapy or transplantation.
Is Aspergillus pneumonia contagious?
No. It cannot spread from one person to another.
When to seek medical advice
- persistent fever and cough
- breathlessness after heavy mould or dust exposure
- worsening chest pain or breathing difficulty
- symptoms of pneumonia that do not improve
Urgent medical care is required if breathing becomes severely difficult or symptoms worsen rapidly.
Author and review information
Author: Aspergillosis Website Editorial Team
Audience: Patients, carers, GPs and non-specialists
Last reviewed: 11 March 2026
References
- Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thorax. 2015 Mar;70(3):270-7. doi: 10.1136/thoraxjnl-2014-206291. Epub 2014 Oct 29. PMID: 25354514.
- Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev. 2011 Sep 1;20(121):156-74. doi: 10.1183/09059180.00001011. PMID: 21881144; PMCID: PMC9584108.
- Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, Segal BH, Steinbach WJ, Stevens DA, Walsh TJ, Wingard JR, Young JA, Bennett JE. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Aug 15;63(4):e1-e60. doi: 10.1093/cid/ciw326. Epub 2016 Jun 29. PMID: 27365388; PMCID: PMC4967602.
